Safety and efficacy of direct oral anticoagulants in comparison to warfarin in obese patients with atrial fibrillation: A systematic review and meta‐analysis

Abstract Background and Aim Obesity affects nearly 650 million adults worldwide, and the prevalence is steadily rising. This condition has significant adverse effects on cardiovascular health, increasing the risk of hypertension, coronary artery disease, heart failure, and atrial fibrillation (AF). ...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Health Science Reports
المؤلفون الرئيسيون:	Alla Adelkhanova, Prakash Raj Oli, Dhan Bahadur Shrestha, Jurgen Shtembari, Vivek Jha, Ghanshyam Shantha, George Michael Bodziock, Monodeep Biswas, Muhammad Omer Zaman, Nimesh K. Patel
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Wiley 2024-04-01
الموضوعات:	anticoagulation apixaban atrial fibrillation edoxaban obesity rivaroxaban
الوصول للمادة أونلاين:	https://doi.org/10.1002/hsr2.2044